Is Eli Lilly and Company (LLY.TO) a Buy, Sell, or Hold?
Eli Lilly and Company
TSX:LLY.TO
$41.09 CAD
-$0.36 (-0.87%)
- Volume
- 58.61K
- Average Volume
- 81.95K
- Market Capitalization
- $1.42T
- P/E Ratio
- 40.61
- Dividend Yield
- 0.56%
- Price Target
- $
- Year High
- $44.80
- Year Low
- $30.67
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.22
- Current Ratio
- $1.50
Industry, Sector & symbol
| Stock Exchange | TSX |
| CEO | David A. Ricks |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Current Symbol | LLY.TO |
| CUSIP | 28655A106 |
| CIK | None |
| Web | https://www.lilly.com |
| Phone | None |
| Currency | CAD |
| Employees | 50000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 1.39 |
| Payout Ratio | 0.22 |
| Current Ratio | 1.50 |
| Quick Ratio | 1.10 |
| Cash Ratio | 0.14 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 14.93 |
| Cash Flow | 15.18 |
| Price / Cash Flow | 79.42 |
| Price / Book | 32.84 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $ |
| Trailing P/E Ratio | 40.61 |
| PEG Ratio | 0.32 |
| P/E Growth | 0.32 |
| Net Income | $- |
| Net Margin | 34.98% |
| Pretax Margin | 43.08% |
| Return on Equity | 101.30% |
| Return on Assets | 21.68% |
Financials Score
| AltmanZ Score | |
| Piotroski Score | |
| Working Capital | - |
| Total Assets | - |
| Ebit | - |
| Market Cap | - |
| Total Liabilities | - |
Poll Results
About Eli Lilly and Company (TSX:LLY.TO) Stock
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN. ...
Frequently Asked Questions
-
What is the current Eli Lilly and Company (LLY.TO) stock price?
-
Eli Lilly and Company(TSX:LLY.TO) stock price is $41.09 in the last trading session. During the trading session, LLY.TO stock reached the peak price of $44.8 while $30.67 was the lowest point it dropped to. The percentage change in LLY.TO stock occurred in the recent session was --0.87% while the dollar amount for the price change in LLY.TO stock was -$-0.36.
-
LLY.TO's industry and sector of operation?
-
The TSX listed LLY.TO is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of LLY.TO?
-
|
|
|
|
| -
How many employees does LLY.TO have?
-
Number of LLY.TO employees currently stands at 50000. LLY.TO operates from P.O. Box 73, Exchange Tower 130 King Street West, Suite 900, Indianapolis, IN M5X 1B1, US.
-
Link for LLY.TO official website?
-
Official Website of LLY.TO is: https://www.lilly.com
-
How do I contact LLY.TO?
-
LLY.TO could be contacted at phone #None and can also be accessed through its website. LLY.TO operates from P.O. Box 73, Exchange Tower 130 King Street West, Suite 900, Indianapolis, IN M5X 1B1, US.
-
How many shares of LLY.TO are traded daily?
-
The average number of LLY.TO shares traded daily for last 3 months was 81.95K.
-
What is the market cap of LLY.TO currently?
-
The market value of LLY.TO currently stands at $1.42T with its latest stock price at $41.09